Physicians' attitudes toward post-MI aspirin prophylaxis: Findings from an online questionnaire in Asia-Pacific

Postgraduate Medicine

Volumn 122, Issue 1, 2010, Pages 108-117

  Zaninelli, Augusto ^a   Hu, Da Yi ^b   Kaufholz, Carola ^c   Schwappach, David ^d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^c Bayer Consumer Care AG   (Switzerland)

^d Institut fur Sucht und Gesundheitsforschung Zurich   (Switzerland)

Author keywords

ACT study; Aspirin; Compliance; Myocardial infarction; Online survey

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRESSLER SYNDROME; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MONOTHERAPY; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PROPHYLAXIS; QUESTIONNAIRE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ASIA; ASPIRIN; ATTITUDE OF HEALTH PERSONNEL; HEALTH CARE SURVEYS; HUMANS; INTERNET; MIDDLE EAST; MYOCARDIAL INFARCTION; PACIFIC OCEAN; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; QUESTIONNAIRES;

EID: 76249121764     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.01.2104     Document Type: Article

References (19)

1. Hennekens CH, Schneider WR. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease. Exp Rev Cardiovasc Ther. 2008;6(1):95-107.
2. The Center for Global Health and Economic Development. A Race Against Time. The Challenge of cardiovascular Disease in Developing Economies. New York, NY: The Trustees of Columbia University in the City of New York; 2004.
3. Abegunde DO, Mathers CD, Adam T, et al. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370(9603):1929-1938.
4. Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet. 2005;366(9496): 1578-1582.
5. Antithrombotic Trialists' (ATT) Collaboration; Baigent C, Blackwell L, Collins R. Ct al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet. 2009;373(9678):1849-1860.
6. Yoon YE, Rivera JJ, Kwon DA, et al. National Cholesterol Education Panel III guidelines performance role in preventing myocardial infarction in a large cohort without a history of coronary artery disease: Korea Acute Myocardial Infarction Registry study. Prev Cardiol. 2009;12(2):109-113.
7. Zaninelli A, Kaufholz C, Schwappach D. Physicians' attitudes toward post-MI aspirin prophylaxis: findings from an online questionnaire in Europe and Latin America. Postgrad Med. 2009;121(6):44-53.
8. Khalil MZ, Abba AA. Management of acute myocardial infarction. Do we follow guidelines applied in practice? Saudi Med J. 2003;24(11):1234- 1237.
9. Bi Y, Gao R, Patel A, et al. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization; results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. Am Heart. 2009;157(3):509-516.
10. Arakawa T, Fujiwara Y, Sollano JD, et al. A questionnaire-based survey on the prescription of non-steroidal anti-inflammatory drugs by physicians in East Asian countries in 2007. Digestion. 2009;79(3): 177-185.
11. Chang LC, Huang N, Chou YJ, et al. Patterns of combined prescriptions of aspinn-Ginkgo biloba in Taiwan: a population-based study. J Clin Pharm Ther. 2008;33(3):243-249.
12. Niu S, Zhao D, Zhu J, et al; BRIG Project. The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project. Am Heart J. 2009;157(4):709-715.
13. Ishikawa S, Kayaba K, Gotoh T, et al. Incidence of total stroke, stroke subtypes, and myocardial infarction in the Japanese population: the JMS Cohort Study. J Epidemiol. 2008:18(4):144-150.
14. Guthrie RM. The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther. 2001;23(6):970-980.
15. Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004;19(11):1096-1103.
16. Patel NC, Crismon ML, Miller AL, Johnsrud MT. Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy. Pharmacotherapy. 2005;25(9):1242-1247.
17. Cohen M. Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care. Mayo Clin Proc. 2009;84(2):149-160.
18. Lin LJ, Cheng MH, Lee CH, et al. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation - a nationwide descriptive study in Taiwan. Clin Ther. 2008;30(9):1726-1736.
19. Miura K, Nakagawa H. Ohashi Y, et al. Four blood pressure indexes and the risk of stroke and myocardial infarction in Japanese men and women: a meta-analysis of 16 cohort studies. Circulation. 2009; 119(14): 1892-1898.